CannabisNewsWire
Editorial Coverage: Bolstered by millennia of anecdotal
evidence and ever-mounting scientific validation, cannabidiol (CBD)
is rapidly being integrated into myriad mainstream consumer
wellness products around the globe.
- Global cannabis market expected to quadruple to over $63
billion by 2024
- CBD oil market to grow at CAGR of 39.19 percent through
2021
- CBD products exploding into a wide variety of product
lines
- Diversified, sales-driven companies expected to outpace
standard growth curve
Humans have used hemp, a variety of Cannabis sativa and a
primary source of CBD, for more than 10,000 years in food, textiles
and medicine. The world is again recognizing the therapeutic
benefits of hemp extracts, and consumers are embracing
cannabis-based products at a breakneck pace. Consumer demand has
triggered an explosion of product innovations that range from oils
and edibles to pet products and infused beverages. Intent on
staying at the vanguard of the upsurge in CBD-based wellness
products, sales and marketing powerhouse Youngevity
International, Inc. (NASDAQ: YGYI) (YGYI
Profile) recently expanded its HempFX™ line with the
launch of two new hemp-derived cannabidiol products. Others are
entering the sector as well. Beer and spirits conglomerate
Constellation Brands, Inc. (NYSE: STZ) just made
the largest investment to date in the cannabis industry.
AbbVie Inc. (NYSE: ABBV) was one of the first
companies to enter the pharmaceutical cannabis space with Marinol,
which is almost chemically identical to THC, the main component in
marijuana. Lexaria Bioscience Corp. (CSE: LXX) (OTC:
LXRP) offers DehydraTECH, a drug delivery platform that
could be a game changer for several industries, including the
recreational and medical cannabis markets. And Neptune
Wellness Solutions, Inc. (NASDAQ: NEPT) recently received
a Confirmation of Readiness letter from Health Canada, a key
milestone in its quest to become a licensed producer of cannabis
oil in Canada.
To view an infographic of this editorial, click here.
The CBD Boom
Cannabidiol is understandably generating worldwide interest from
both the scientific and investment communities. It’s hard to ignore
a market sector projected to nearly quadruple from about $16
billion last year to more than $63 billion
worldwide by 2024. In just the United States alone, the
marijuana industry could create an economic tsunami estimated to
surge past $75 billion annually
by 2022.
Explosive demand projections are attributed to increased public
awareness about wide-ranging potential health benefits, natural
pain mitigation and anti-inflammatory properties, advancements in
cultivation and processing, plus the convenience and reach of
online and direct retailing — all of which contribute to a global
CBD oil market expected to grow at an
eye-popping CAGR of 39.19 percent through 2021. The upward
trend is indisputable, and corporations are jockeying for position,
racing to produce a variety of CBD products, staking out
distribution channels and opening a realm of possibilities in
previously unimagined markets. All the projections and activity
send clear signals of what’s to come.
The Mission Matters
With deep roots in health and nutrition spanning over 20 years,
omni-direct lifestyle company Youngevity
International, Inc. (NASDAQ: YGYI) is still dedicated
to the core mission of its founder: learning how to live younger,
longer. Expanding on the pioneering biomedical research of Dr. Joel
D. Wallach, Youngevity is aggressively and ethically growing its
business through a unique admixture of direct selling, traditional
marketing, mergers and acquisitions, and stellar organic growth.
The direct sales model and international roll-out strategies of
Youngevity provide synergistic leverage to capitalize on the
immense potential in high-growth emerging markets, exactly what’s
occurring in the CBD arena.
Youngevity’s recent
announcement about the launch of two new hemp-derived
cannabidiol products in its HempFX line intermeshes with the
company’s explosive sales growth and its mission to provide
nutritional and lifestyle solutions to achieve optimum health and
wellness goals. “Plant-based nutrition is fundamental to our
product development philosophy,” stated Youngevity CEO Steve
Wallach.
The new HempFX products expand YGYI’s CBD line and join a vast
stable of more than one thousand products and services the company
already offers. The new tablet-based CBD products are designed to
work in conjunction with Youngevity’s Y-DR8+ proprietary water
bottle system. The company’s exclusive Y-DR8 filter utilizes
activated carbon cloth designed to reduce chemicals and deliver CBD
in great tasting water. The portable Y-DR8 filter holds cannabidiol
tablets above the water line, and YGYI’s CBD formulations are
infused into the water as it flows over the tablets.
“This bottle system is intended to provide people with a
revolutionary point-of-use water system for great tasting water and
enables consumers to customize tap water based upon their health
and wellness needs. It is a beverage technology that we expect will
have broad consumer appeal and we are extremely excited to combine
this technology with the benefits of hemp-based CBD,” stated Vice
President of Innovation and Emerging Markets Rick Anson.
Using patent-pending extraction and bioavailability processes,
YGYI’s HempFX products contain only U.S. organically grown non-GMO
hemp. The full-spectrum phytocannabinoids are third-party tested to
ensure only the highest quality allergen-, gluten- and THC-free
hemp oils are produced and sold to the public in compliance with
good manufacturing practice (GMP) standards.
HempFX Hydration™ – Sleep is formulated to improve sleep
patterns and deliver the health benefits of CBD. YGYI’s
high-quality cannabidiol formulation contains melatonin and is
administered using the company’s proprietary beverage enhancement
tablet. HempFX Hydration – Pure contains 25 mg of organic,
full-spectrum, hemp-derived cannabidiol oil per tablet and quickly
dissolves in water as it is consumed.
“Plant-based nutrition is fundamental to our product development
philosophy,” Wallach stated. “That’s why we’re especially excited
to enter this rapidly growing market with two new products.”
HempFX Hydration – Sleep and HempFX Hydration – Pure are
expected to be available next month, and sales may well outperform
YGYI’s three other hemp-based products, which sold out of
preproduction quantities during the company’s August sales
convention.
Sales and Marketing Powerhouse
Recognized as one of the Top 100 Global
Direct Selling Companies, Youngevity is a sales powerhouse that
more than doubled revenues from $75 million in 2012 to $166 million
in 2017. The company shows no signs of slowing down, posting an 8.7
percent revenue increase in Q2 YTD 2018 over Q2 YTD 2017 and a 9.6
percent increase in gross profits over the same period.
The NASDAQ-listed company, added to the Russell Index in June,
operates in large, scalable global market segments driving
significant revenue growth in skin care, anti-aging, weight loss,
brain health and coffee. The expansion into CBD products appears
likely to boost revenues even further, potentially placing the
company at the forefront of the CBD boom. Making quality products
is only one aspect of carving out space in this new sector;
sell-through is the more important criteria to measure success
during the upswing.
Youngevity’s unique marketing hybrid buttressing the
direct-selling business model with powerful e-commerce and social
selling initiatives has created a global panoply of products and
services under one corporate umbrella that supports healthy,
empowered lifestyles. Youngevity now offers more than one thousand
high-quality nutritional and lifestyle products and services
through a wide range of channels in fast-growing retail
categories:
- Health and Nutrition
- Home and Family
- Food and Beverage
- Spa and Beauty
- Fashion
- Essential Oils
- Photo and Scrapbooking
- Services for Home and Business
“One thing that makes
Youngevity so unique is our broad product offering,” President
and CFO Dave Briskie stated during the company’s 2018 convention.
“It allows us to reach many markets and gives our customers a wide
range of high-quality lifestyle products. We will continue to do
our best to align our products to the needs of our market.”
The Epiphany
There’s little doubt about the trajectory of the global CBD
market. Some have likened the impending surge of industry players
to the dot.com era — some will become Amazon.com while others will
disappear faster than Pets.com. Investors looking to capitalize on
the immense opportunity ahead are likely best served by strategic
positions in diversified companies driven by sales and galvanized
by a mission to excel.
Others in the Arena
Constellation Brands, Inc. (NYSE: STZ) just
made the largest investment to date in the cannabis space. The
company is already a leading international producer and marketer of
beer, wine and spirits. With its $4 billion investment in Canopy
Growth Corp. (NYSE: CGC), Constellation looks to accelerate its
market position and expand its portfolio in emerging cannabis
markets around the globe.
Primarily a pharmaceutical company, AbbVie Inc. (NYSE:
ABBV) offers a synthetic cannabis-based drug on the
market. Marinol is an FDA-approved, prescription drug used to
alleviate nausea or vomiting for chemotherapy patients; it may also
help AIDS patients who have lost their desire to eat.
Lexaria Bioscience Corp.’s (CSE: LXX) (OTC:
LXRP) DehydraTECH drug delivery platform features a
patented, cost-effective delivery mechanism that improves the taste
and smell — as well as the bio-absorption — of ingestible
substances. Cannabinoid-infused edibles and concentrates represent
the fastest-growing segments of the cannabis industry, and
DehydraTECH may position Lexaria as a prime partner for offerings
in these spaces.
Working to develop unique extracts and formulations in the legal
cannabis wellness field, Neptune Wellness Solutions, Inc.
(NASDAQ: NEPT) is well on its way to obtaining official
approval to move forward. The Confirmation of Readiness letter
“brings us to the threshold of becoming a Licensed Producer of
cannabis oil in Canada, and is a very exciting moment," said
Neptune president and CEO Jim Hamilton. "Our
entry into the legal cannabis industry leverages our established
expertise in the development of innovative Omega3 oil products,
navigating global regulatory frameworks, worldwide
commercialization of wellness solutions, and production of
high-quality extracts.”
For more information on Youngevity, visit Youngevity
International, Inc. (NASDAQ: YGYI)
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides
(1) access to our news aggregation and syndication servers, (2)
CannabisNewsBreaks that summarize
corporate news and information, (3) enhanced press release
services, (4) social media distribution and optimization services,
and (5) a full array of corporate communication solutions. As a
multifaceted financial news and content distribution company with
an extensive team of contributing journalists and writers, CNW is
uniquely positioned to best serve private and public companies that
desire to reach a wide audience of investors, consumers,
journalists and the general public. CNW has an ever-growing
distribution network of more than 5,000 key syndication outlets
across the country. By cutting through the overload of information
in today’s market, CNW brings its clients unparalleled visibility,
recognition and brand awareness. CNW is where news, content and
information converge.
Receive Text Alerts
from CannabisNewsWire: Text "Cannabis" to
21000
For more information please visit https://www.CannabisNewsWire.com and
or https://CannabisNewsWire.News
Please see full terms of use and disclaimers on the
CannabisNewsWire website applicable to all content provided by CNW,
wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net
DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article
and content set forth above. References to any issuer other than
the profiled issuer are intended solely to identify industry
participants and do not constitute an endorsement of any issuer and
do not constitute a comparison to the profiled issuer. The
commentary, views and opinions expressed in this release by CNW are
solely those of CNW. Readers of this Article and content agree that
they cannot and will not seek to hold liable CNW for any investment
decisions by their readers or subscribers. CNW is a news
dissemination and financial marketing solutions provider and is NOT
registered broker-dealers/analysts/investment advisers, hold no
investment licenses and may NOT sell, offer to sell or offer to buy
any security.
The Article and content related to the profiled company
represent the personal and subjective views of the Author, and are
subject to change at any time without notice. The information
provided in the Article and the content has been obtained from
sources which the Author believes to be reliable. However, the
Author has not independently verified or otherwise investigated all
such information. None of the Author, CNW, or any of their
respective affiliates, guarantee the accuracy or completeness of
any such information. This Article and content are not, and should
not be regarded as investment advice or as a recommendation
regarding any particular security or course of action; readers are
strongly urged to speak with their own investment advisor and
review all of the profiled issuer’s filings made with the
Securities and Exchange Commission before making any investment
decisions and should understand the risks associated with an
investment in the profiled issuer’s securities, including, but not
limited to, the complete loss of your investment.
CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E the Securities Exchange Act of 1934, as amended and
such forward-looking statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. “Forward-looking statements” describe future expectations,
plans, results, or strategies and are generally preceded by words
such as “may”, “future”, “plan” or “planned”, “will” or “should”,
“expected,” “anticipates”, “draft”, “eventually” or “projected”.
You are cautioned that such statements are subject to a multitude
of risks and uncertainties that could cause future circumstances,
events, or results to differ materially from those projected in the
forward-looking statements, including the risks that actual results
may differ materially from those projected in the forward-looking
statements as a result of various factors, and other risks
identified in a company’s annual report on Form 10-K or 10-KSB and
other filings made by such company with the Securities and Exchange
Commission. You should consider these factors in evaluating the
forward-looking statements included herein, and not place undue
reliance on such statements. The forward-looking statements in this
release are made as of the date hereof and CNW undertakes no
obligation to update such statements.
Source:
CannabisNewsWire
Contact:
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net